Skip to content

Clinical study of lingzhu powder on the prevention and treatment of children with (complex) febrile convulsion (acute severe attack wind heat dynamic wind syndrome)

Clinical study of lingzhu powder on the prevention and treatment of children with (complex) febrile convulsion (acute severe attack wind heat dynamic wind syndrome)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044757
Enrollment
Unknown
Registered
2021-03-26
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

febrile seizure

Interventions

Sponsors

The First Affiliated Hospital of He'nan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Conform to the diagnostic criteria of febrile convulsion proposed in "Expert Consensus on Diagnosis, Treatment and Management of Febrile Convulsion (2017)" by Neurology Group of Pediatrics Society of Chinese Medical Association; 2. Meet the syndrome differentiation standards of "Acute Severe Attack Wind Heat Dynamic Wind Syndrome" in "Guidelines for the Diagnosis and Treatment of Common Diseases in Pediatrics of Traditional Chinese Medicine" issued by the State Administration of Traditional Chinese Medicine in 2012; 3. Convulsion more than 3 times in 6 months or 4 times in a year; 4. Aged from 6 months to 10 years; No gender limitations; 5. Received informed consent and volunteer to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Convulsions caused by central nervous system infection, epilepsy, toxic encephalopathy, metabolic disorders, acute intoxication or genetic metabolic diseases and other etiologies; 2. Patients without fever during convulsion; 3. Use of any investigational drug within 1 month or 10 half-periods prior to screening; 4. Patients who are known to be allergic to the components of Lingzhu powder; 5. Patients with a history of mental illness or congenital mental retardation; 6. Suffer from serious liver and kidney diseases, blood system diseases, malignant tumors, autoimmune diseases, chronic serious infections, etc..

Design outcomes

Primary

MeasureTime frame
blood routine test;urine routine test;liver function;renal function;electroencephalogram;MR;

Countries

China

Contacts

Public ContactMa Bingxiang

The First Affiliated Hospital of He'nan University of Chinese Medicine

mbx1963@126.com+86 13592601575

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026